Description: YONSA® is the first and only 500 mg dose of abiraterone acetate approved by the FDA, when used with methylprednisolone. The most common adverse drug reactions (≥10%) reported in the two randomized clinical trials that occurred more commonly (
micronization (12) prostate pills (9) abiraterone acetate (8) abiraterone (7) prostate cancer medication (7) abiraterone side effects (7) metastasis prostate cancer (6) metastatic prostate cancer (3) advanced technology formulation mcrpc therapy